Novel Vaccine Strategy to CMV Based on a Disc Virus

Abstract: 

Novel Vaccine Strategy to CMV Based on a Disc Virus

These researchers are exploring the ability of a novel replication impaired virus, with improved characteristics to induce both T cell and antibody responses against GPCMV, to protect against congenital human cytomegalovirus (CMV) infection in comparison to a single subunit gB vaccine. In order to accomplish this, they need to design new primers and probes for PCR-based dection as well as looking at peptide sequences for epitope mapping. MSI resources are helpful in accomplishing these goals.

Group name: 
choiky